(Q43872554)

27 November 2017

Antimüllerian hormone serum levels: a putative marker for ovarian aging (English)

1 reference

27 November 2017

5

Bart C J M Fauser

1 reference

27 November 2017

Annemarie de Vet

1

1 reference

27 November 2017

Joop S E Laven

series ordinal

2

1 reference

27 November 2017

Frank H de Jong

series ordinal

3

1 reference

27 November 2017

Axel P N Themmen

series ordinal

4

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 February 2002

1 reference

27 November 2017

Fertility and Sterility

1 reference

27 November 2017

77

1 reference

27 November 2017

357-362

1 reference

27 November 2017

2

1 reference

Human growth differentiation factor 9 (GDF-9) and its novel homolog GDF-9B are expressed in oocytes during early folliculogenesis

27 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Oocyte-specific expression of growth/differentiation factor-9

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Wilms' tumor protein WT1 as an ovarian transcription factor: decreases in expression during follicle development and repression of inhibin-alpha gene promoter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Prolongation of ovarian lifespan into advanced chronological age by Bax-deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Growth differentiation factor-9 is required during early ovarian folliculogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Mutations in an oocyte-derived growth factor gene (BMP15) cause increased ovulation rate and infertility in a dosage-sensitive manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Mullerian inhibiting substance: a gonadal hormone with multiple functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

A quantitative and cytological study of germ cells in human ovaries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

An immunoassay to detect human müllerian inhibiting substance in males and females during normal development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Mullerian inhibiting substance in humans: normal levels from infancy to adulthood.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Serum müllerian-inhibiting substance levels during normal menstrual cycles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Manipulation of human ovarian function: physiological concepts and clinical consequences

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Initial and Cyclic Recruitment of Ovarian Follicles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Basal follicle-stimulating hormone levels are of limited value in predicting ongoing pregnancy rates after in vitro fertilization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Day 3 serum inhibin-B is predictive of assisted reproductive technologies outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Inhibin-B as a test of ovarian reserve for infertile women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Day 3 serum inhibin B and FSH and age as predictors of assisted reproduction treatment outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Antral follicle counts by transvaginal ultrasonography are related to age in women with proven natural fertility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Developmental and endocrine aspects of normal ovarian aging.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Follicle pool depletion: factors involved and implications

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Lack of correlation between maximum early follicular phase serum follicle stimulating hormone concentrations and menstrual cycle characteristics in women under the age of 35 years.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Low-dose exogenous FSH initiated during the early, mid or late follicular phase can induce multiple dominant follicle development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Growth patterns of nondominant ovarian follicles during the normal menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

Anti-müllerian hormone: the Jost factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2801%2902993-4

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0015-0282(01)02993-4

1 reference

27 November 2017

1 reference